Tue, October 13, 2020

David Lebovitz Maintained (ASND) at Buy with Increased Target to $194 on, Oct 13th, 2020

David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $179 to $194 on, Oct 13th, 2020.

David has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $158 on, Friday, August 28th, 2020